Dexcom | DXCM - Cost Of Sales

Stock Price
69.97
Daily Change
0.08 0.11%
Monthly
-0.19%
Yearly
-20.56%
Q1 Forecast
70.79

Dexcom reported $477.9M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Abbott USD 4.92B 535M Dec/2025
Align Technology USD 363.97M 7.48M Dec/2025
AtriCure USD 32.94M 1.72M Sep/2025
Avanos Medical USD 91.8M 8.9M Sep/2025
Baxter International USD 1.88B 66M Sep/2025
Becton, Dickinson and Co. USD 5.19B 2.32B Sep/2025
Boston Scientific USD 1.84B 82M Dec/2025
Cooper Companies USD 464.2M 45.9M Sep/2025
Dexcom USD 477.9M 9.6M Sep/2025
Edwards Lifesciences USD 345.2M 800K Sep/2025
Globus Medical USD 282.38M 3.42M Sep/2025
Hologic USD 463.7M 5.1M Dec/2025
Insulet USD 196.2M 700K Sep/2025
Integra LifeSciences USD 195.07M 11.2M Sep/2025
J&J USD 7.97B 689M Dec/2025
Masimo USD 140.9M 3.3M Sep/2025
Medtronic USD 3.52B 80M Sep/2025
Merit Medical Systems USD 197.75M 229K Sep/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Solventum Corp USD 963M 23M Sep/2025
Stryker USD 2.69B 373M Dec/2025
Tandem Diabetes Care USD 114.96M 138K Sep/2025
Teleflex USD 461.38M 111.57M Sep/2025
West Pharmaceutical Services USD 510.3M 17.7M Sep/2025
Zimmer Biomet Holdings USD 735.8M 17M Sep/2025